Skip to main content

Rothblatt Martine A's Form 4 filing

United Therapeutics Corp (UTHR) · filed May 2, 2023

Accession no.
0001415889-23-007092
Filed
May 2, 2023
Trade date
Apr 28-May 1, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.69M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rothblatt Martine ACIK 0001106578Director, Officer (CHAIRPERSON & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 28, 2023Common StockMOption exerciseAcquired+8,000$113.08+$904,6408,130Direct
Apr 28, 2023Common StockSSaleDisposed−952$227.93F2−$216,989.367,178Direct
Apr 28, 2023Common StockSSaleDisposed−2,758$228.94F3−$631,416.524,420Direct
Apr 28, 2023Common StockSSaleDisposed−4,114$229.85F4−$945,602.9306Direct
Apr 28, 2023Common StockSSaleDisposed−176$230.41F5−$40,552.16130Direct
May 1, 2023Common StockMOption exerciseAcquired+8,000$113.08+$904,6408,130Direct
May 1, 2023Common StockSSaleDisposed−1,194$229.84F6−$274,428.966,936Direct
May 1, 2023Common StockSSaleDisposed−2,332$230.82F7−$538,272.244,604Direct
May 1, 2023Common StockSSaleDisposed−3,399$231.87F8−$788,126.131,205Direct
May 1, 2023Common StockSSaleDisposed−1,075$232.92F9−$250,389130Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 28, 2023Common StockMOption exerciseDisposed−8,000$0.00$016,000Direct
May 1, 2023Common StockMOption exerciseDisposed−8,000$0.00$08,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $227.285 to $228.275. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $228.38 to $229.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $229.38 to $230.375. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $230.38 to $230.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $229.225 to $230.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $230.33 to $231.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $231.345 to $232.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $232.37 to $233.245. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)